US biopharmaceutical company Athira Pharma, based in Washington state, has agreed to pay more than $4 million (£3.3 million) ...

On January 6, the Department of Justice (DOJ) announced that Athira Pharma Inc., a Washington-based biopharmaceutical company, agreed to pay over ...

Bothell-based biopharmaceutical company Athira Pharma Inc. (Nasdaq: ATHA) is paying a $4.1 million fine due to allegations it used doctored research to land a National Institutes of Health grant.

Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies. The Department of Justice said Monday ...

Seattle-area biotech company Athira Pharma agreed to pay $4.07 million to settle allegations that it violated the False Claims Act by failing to disclose research misconduct to federal agencies ...

Robert Renninger, the Vice President of Finance at Athira Pharma, Inc. (NASDAQ:ATHA), recently executed several transactions involving the company's stock, according to a filing with the ...

A biopharmaceutical company, Athira Pharma, settled for $4.068 million over allegations of research misconduct.

Athira Pharma (ATHA) agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act by failing to report allegations of research misconduct to the National Institutes of ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Stressing the importance of integrity in taxpayer-funded biomedical research, the U.S. Department of Justice reported that Athira Pharma Inc. agreed to pay more than $4 million to resolve False Claims ...

BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health ...